Skip to main content
Explore URMC

URMC Logo

menu

Barbara L. Asselin, M.D.

Pediatrics

Publications

Showing all 93 journal articles & 18 books available

Journal Articles

2018
Dwyer-Matzky K, Blatt A, Asselin BL, Wood DL. "Lack of Preparedness for Pediatric to Adult-Oriented Health Care Transition in Hospitalized Adolescents and Young Adults." Academic pediatrics.. 2018 18(1):102-110. Epub 2017 Aug 01.

10/2016
Ladas EJ, Orjuela M, Stevenson K, Cole PD, Lin M, Athale UH, Clavell LA, Leclerc JM, Michon B, Schorin MA, Welch JG, Asselin BL, Sallan SE, Silverman LB, Kelly KM. "Dietary intake and childhood leukemia: The Diet and Acute Lymphoblastic Leukemia Treatment (DALLT) cohort study." Nutrition.. 2016 Oct 0; 32(10):1103-1109.e1. Epub 2016 Mar 28.

9/2016
Matlawska-Wasowska K, Kang H, Devidas M, Wen J, Harvey RC, Nickl CK, Ness SA, Rusch M, Li Y, Onozawa M, Martinez C, Wood BL, Asselin BL, Chen IM, Roberts KG, Baruchel A, Soulier J, Dombret H, Zhang J, Larson RS, Raetz EA, Carroll WL, Winick NJ, Aplan PD, Loh ML, Mullighan CG, Hunger SP, Heerema NA, Carroll AJ, Dunsmore KP, Winter SS. "MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study." Leukemia.. 2016 Sep 0; 30(9):1909-12. Epub 2016 Mar 08.

8/2016
Rodriguez V, Kairalla J, Salzer WL, Raetz EA, Loh ML, Carroll AJ, Heerema NA, Wood BL, Borowitz MJ, Burke MJ, Asselin BL, Devidas M, Winick NJ, Carroll WL, Hunger SP, Dreyer ZE. "A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1." Journal of pediatric hematology/oncology.. 2016 Aug 0; 38(6):409-17.

3/10/2016
Asselin BL, Devidas M, Chen L, Franco VI, Pullen J, Borowitz MJ, Hutchison RE, Ravindranath Y, Armenian SH, Camitta BM, Lipshultz SE. "Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2016 Mar 10; 34(8):854-62. Epub 2015 Dec 23.

12/2015
Place AE, Stevenson KE, Vrooman LM, Harris MH, Hunt SK, O'Brien JE, Supko JG, Asselin BL, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJ, Lipshultz SE, Kutok JL, Blonquist TM, Neuberg DS, Sallan SE, Silverman LB. "Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial." The Lancet. Oncology.. 2015 Dec 0; 16(16):1677-90. Epub 2015 Nov 06.

8/20/2015
Chow EJ, Asselin BL, Schwartz CL, Doody DR, Leisenring WM, Aggarwal S, Baker KS, Bhatia S, Constine LS, Freyer DR, Lipshultz SE, Armenian SH. "Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2015 Aug 20; 33(24):2639-45. Epub 2015 May 26.

7/2015
Winter SS, Dunsmore KP, Devidas M, Eisenberg N, Asselin BL, Wood BL, Leonard Rn MS, Murphy J, Gastier-Foster JM, Carroll AJ, Heerema NA, Loh ML, Raetz EA, Winick NJ, Carroll WL, Hunger SP. "Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434." Pediatric blood & cancer.. 2015 Jul 0; 62(7):1176-83. Epub 2015 Mar 08.

6/2015
Bleyer A, Asselin BL, Koontz SE, Hunger SP. "Clinical application of asparaginase activity levels following treatment with pegaspargase." Pediatric blood & cancer.. 2015 Jun 0; 62(6):1102-5. Epub 2014 Nov 12.

2015
Asselin BL, Rizzari C. "Asparaginase pharmacokinetics and implications of therapeutic drug monitoring.doi: 10.3109/10428194.2014.1003056 [Epub ahead of print]." Leuk Lymphoma. 2015; : 1-26.

12/2014
Asselin BL, Fisher V. "Impact of clinical and subclinical hypersensitivity to asparaginase in acute lymphoblastic leukemia." Clinical journal of oncology nursing.. 2014 Dec 0; 18(6):E107-12.

11/2014
Salzer WL, Asselin BL, Plourde PV, Corn T, Hunger SP. "Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia." Annals of the New York Academy of Sciences.. 2014 Nov 0; 1329:81-92. Epub 2014 Aug 05.

7/2014
Tower RL, Jones TL, Camitta BM, Asselin BL, Bell BA, Chauvenet A, Devidas M, Halperin EC, Pullen J, Shuster JJ, Winick N, Kurtzberg J. "Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group." Journal of pediatric hematology/oncology.. 2014 Jul 0; 36(5):353-61.

2014
Tower RL, Jones TL, Camitta BM, Asselin BL, Bell BA, Chauvenet A, Devidas M, Halperin EC, Pullen J, Shuster JJ, Winick N, and Kurtzberg J. "Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: A report from the Children's Oncology Group." Journal of Pediatric Hematology/Oncology. 2014; 36(5): 353-61.

2014
Salzer WL, Asselin BL, Plourde PV, Corn T, and Hunger SP. "Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia." Acad Sci. 2014; 1329(2014): 81-92.

2014
Bleyer A, Asselin BL, Koontz SE, and Hunger SP. "Clinical application of asparaginase activity levels following treatment with pegaspargase.doi: 10.1002/pbc.25299. [Epub ahead of print]". Pediatr Blood Cancer. 2014; .

2014
Asselin BL, Fisher V. "Impact of clinical and subclinical hypersensitivity to asparaginase in acute lymphoblastic leukemia. [Epub ahead of print] doi: 10.1188/14.CJON". Clin J Oncol Nurs. 2014; 18(6): E102-12.

12/2013
Asselin BL, Gaynon P, Whitlock JA. "Recent advances in acute lymphoblastic leukemia in children and adolescents: an expert panel discussion." Current opinion in oncology.. 2013 Dec 0; 25 Suppl 3:S1-13; quiz S14-6.

10/1/2013
Lipshultz SE, Lipsitz SR, Kutok JL, Miller TL, Colan SD, Neuberg DS, Stevenson KE, Fleming MD, Sallan SE, Franco VI, Henkel JM, Asselin BL, Athale UH, Clavell LA, Michon B, Laverdiere C, Larsen E, Kelly KM, Silverman LB. "Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia." Cancer.. 2013 Oct 1; 119(19):3555-62. Epub 2013 Jul 16.

7/25/2013
Salzer WL, Asselin B, Supko JG, Devidas M, Kaiser NA, Plourde P, Winick NJ, Reaman GH, Raetz E, Carroll WL, Hunger SP. "Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group." Blood.. 2013 Jul 25; 122(4):507-14. Epub 2013 Jun 05.

3/20/2013
Vrooman LM, Stevenson KE, Supko JG, O'Brien J, Dahlberg SE, Asselin BL, Athale UH, Clavell LA, Kelly KM, Kutok JL, Laverdière C, Lipshultz SE, Michon B, Schorin M, Relling MV, Cohen HJ, Neuberg DS, Sallan SE, Silverman LB. "Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2013 Mar 20; 31(9):1202-10. Epub 2013 Jan 28.

2/20/2013
Liesveld J, Asselin B. "It's ALL in the liposomes: vincristine gets a new package." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2013 Feb 20; 31(6):657-9. Epub 2013 Jan 14.

2013
Sears B, Bailes J, Asselin B. "Therapeutic uses of high-dose omega-3 fatty acids to treat comatose patients with severe brain injury." Pharma Nutrition. 2013; 1: 86-89.

2013
Asselin BL, Gaynon P, Whitlock JA. "Recent advances in acute lymphoblastic leukemia in children and adolescents: an expert panel discussion." Curr Opin Oncol. 2013; 25 Suppl, 3: S1-13; quiz S14-6.

2013
Liesveld J, Asselin B. "It's all in the liposomes: Vincristine gets a new package." J Clin Oncol Epub & J Clin Oncol. 2013; 31(6): 657-9.

2013
Vrooman LM, Stevenson KE, Supko JG, O'Brien J, Dahlberg SE, Asselin BL, Athale UH, Clavell LA, Kelly KM, Kutok JL, Laverdiere C, Lipshultz SE, Michon B, Schorin M, Relling MV, Cohen HJ, Neuberg DS, Sallan SE, and Silverman LB. "Post-induction dexamethasone and individualized dosing of E. coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: Results from a randomized study, Dana-Farber Cancer Institute ALL Consortium Protocol 00-01." J Clin Oncol Epub & J Clin Oncol. 2013; 31(9): 1202-10.

2013
Salzer WL, Asselin B, Supko JG, Devidas M, Kaiser NA, Plourde P, Winick NJ, Reaman GH, Raetz E, Carroll WL, and Hunger SP. "Erwinia asparaginase achieves therapeutic activity after PEG-asparaginase allergy: A report from the Children's Oncology Group." Blood. 2013; 122(4): 507-14.

2013
Lipshultz SE, Lipsitz SR, Kutok JL, Miller TL, Colan SD, Neuberg DS, Stevenson KE, Fleming MD, Sallan SE, Franco VI, Henkel JM, Asselin BL, Athale UH, Clavell LA, Michon B, Laverdiere C, Larsen E, Kelly KM, and Silverman LB. "Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia." Cancer. 2013; 119(19): 3555-62.

12/2012
Lipshultz SE, Miller TL, Lipsitz SR, Neuberg DS, Dahlberg SE, Colan SD, Silverman LB, Henkel JM, Franco VI, Cushman LL, Asselin BL, Clavell LA, Athale U, Michon B, Laverdière C, Schorin MA, Larsen E, Usmani N, Sallan SE, . "Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes." Pediatrics.. 2012 Dec 0; 130(6):1003-11. Epub 2012 Nov 19.

4/1/2012
Lipshultz SE, Miller TL, Scully RE, Lipsitz SR, Rifai N, Silverman LB, Colan SD, Neuberg DS, Dahlberg SE, Henkel JM, Asselin BL, Athale UH, Clavell LA, Laverdière C, Michon B, Schorin MA, Sallan SE. "Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2012 Apr 1; 30(10):1042-9. Epub 2012 Feb 27.

2/16/2012
Asselin BL. "The right dose for the right patient." Blood.. 2012 Feb 16; 119(7):1617-8.

2012
Asselin BL. "Inside Blood: The right dose for the right patient." Blood. 2012; 119(7): 1617-18.

2012
Lipshultz SE, Miller TL, Lipsitz SR, Neuberg DS, Dahlberg SE, Colan SD, Silverman LB, Henkel JM, Franco VI, Cushman LL, Asselin BL, Clavell LA, Athale U, Michon B, Laverdiere C, Schorin MA, Larsen E, Usmani N, Sallan SE. "Continuous versus bolus-infusion of doxorubicin in children with high-risk acute lymphoblastic leukemia: long-term cardiac outcomes." Pediatrics Epub & Pediatrics. 2012; 130(6): 1003-11.

2012
Lipshultz SE, Miller TL, Scully RE, Lipsitz SR, Rifai N, Silverman LB, Colan SD, Neuberg DS, Dahlberg SE, Henkel JM, Asselin BL, Athale UH, Clavell LA, Laverdiere C, Michon B, Schorin MA, and Sallan SE. "Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: Associations with long-term echocardiographic outcomes." J Clin Oncol. 2012; 30(10): 1042-9.

9/2011
Asselin BL. "L-asparaginase for treatment of childhood acute lymphoblastic leukemia: what have we learned?" Pediatric blood & cancer.. 2011 Sep 0; 57(3):357-8. Epub 2011 Apr 20.

7/28/2011
Asselin BL, Devidas M, Wang C, Pullen J, Borowitz MJ, Hutchison R, Lipshultz SE, Camitta BM. "Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)." Blood.. 2011 Jul 28; 118(4):874-83. Epub 2011 Apr 07.

6/2011
Vrooman LM, Neuberg DS, Stevenson KE, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Larsen EC, Laverdière C, Michon B, Schorin M, Schwartz CL, Cohen HJ, Lipshultz SE, Silverman LB, Sallan SE. "The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium." European journal of cancer : official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR).. 2011 Jun 0; 47(9):1373-9. Epub 2011 Apr 20.

2011
Asselin, BL; Devidas, M; Wang, C; Pullen, J; Borowitz, MJ; Hutchison, R; Lipshultz, S; Camitta, BM. "Effectiveness of High Dose Methotrexate in T-cell Lymphoblastic Leukemia and Advanced Stage Lymphoblastic Lymphoma: A Randomized Study by the Children's Oncology Group (POG 9404)". Blood. 2011; 118(4): 874-883.

2011
Asselin, BL. "L-Asparaginase for Treatment of Childhood Acute Lymphoblastic Leukemia: What Have We Learned?". Pediatric Blood Cancer. 2011; 57(3): 357-358.

2011
Lipshultz, SE; Miller, TL; Lipsitz, SR; Neuberg, DS; Dahlberg, SE; Colan, SD; Silverman, LB; Henkel, JM; Cushman, LL; Asselin, BL; Clavell, LA; Athale, U; Michon, B; Laverdiere, C; Schorin, MA; Larsen, E; Usmani, N; Sallan, SE, for the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium. "Late Cardiac Status in Long-Term Survivors of Childhood High-Risk Acute Lymphoblastic Leukemia 8 Years After Continuous or Bolus Infusion of Doxorubicin: The Dana-Farber Cancer Institute ALL 91-01 Randomized Trial". J Clin Oncol. 2011; .

2011
Kurtzberg J; Asselin B; Bernstein M; Buchanan GR; Pollock BH; and Camitta BM. "Polyethylene glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: A Children's Oncology Group Study (POG 8866)". Journal of Pediatric Hematology Oncology. 2011; 33(8): 610-16.

2011
Vrooman LM, Neuberg DS, Stevenson KE, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Larsen EC, Laverdiere C, Michon B, Schorin M, Schwartz CL, Cohen HJ, Lipshultz SE, Silverman LB, and Sallan SE. "The low incidence of secondary acute myelogenous leukemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukemia: A report from the Dana-Farber Cancer Institute ALL Consortium". Eur J Cancer. 2011; 47: 1373-79.

10/2010
Lipshultz SE, Scully RE, Lipsitz SR, Sallan SE, Silverman LB, Miller TL, Barry EV, Asselin BL, Athale U, Clavell LA, Larsen E, Moghrabi A, Samson Y, Michon B, Schorin MA, Cohen HJ, Neuberg DS, Orav EJ, Colan SD. "Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial." The Lancet. Oncology.. 2010 Oct 0; 11(10):950-61. Epub 2010 Sep 16.

2/18/2010
Silverman LB, Supko JG, Stevenson KE, Woodward C, Vrooman LM, Neuberg DS, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Laverdière C, Michon B, Schorin M, Schwartz CL, O'Brien JE, Cohen HJ, Sallan SE. "Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia." Blood.. 2010 Feb 18; 115(7):1351-3. Epub 2009 Dec 10.

2/2010
Vrooman LM, Supko JG, Neuberg DS, Asselin BL, Athale UH, Clavell L, Kelly KM, Laverdière C, Michon B, Schorin M, Cohen HJ, Sallan SE, Silverman LB. "Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia." Pediatric blood & cancer.. 2010 Feb 0; 54(2):199-205.

2/2010
Silverman LB, Stevenson KE, O'Brien JE, Asselin BL, Barr RD, Clavell L, Cole PD, Kelly KM, Laverdiere C, Michon B, Schorin MA, Schwartz CL, O'Holleran EW, Neuberg DS, Cohen HJ, Sallan SE. "Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000)." Leukemia.. 2010 Feb 0; 24(2):320-34. Epub 2009 Dec 17.

2010
Silverman, LB; Stevenson, K; O'Brien, JE; Asselin, BL; Athale, UH; Clavell, L; Cole, PD; Kelly, K; Laverdiere, C; Michon, B; Schorin, M; Schwartz, CL; Whyte, O'Holleran, E; Neuberg, DS; Cohen, HJ; Sallan, SE. "Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)". Leukemia. 2010; 24: 320-334.

2010
Vrooman, LM; Supko, J; Neuberg, DS; Asselin, BL; Athale, UH, Clavell, L; Kelly, K; Laverdiere, C; Michon, B; Schorin, M; Sallan, SE; Silverman, LB. "Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia: pharmacodynamics and tolerability." Pediatric Blood and Cancer. 2010; 54: 199-205.

2010
Silverman, LB; Supko, JG; Stevenson, KE; Woodward, C; Vrooman, LM; Neuberg, DS; Asselin, BL; Athale, UH; Cole, PD; Kelly, KM; Laverdiere, C; Michon, B; Schorin, M; Schwartz, CL; O'Brien, JE; Cohen HJ; Sallan, SE. "Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia." Blood. 2010; 115(7): 1351-53.

2010
Lipshultz SE; Scully RE; Lipsitz SR; Sallan SE; Silverman LB; Miller TL; Barry EV; Asselin BL; Athale U; Clavell LA; Larsen E; Moghrabi A; Samson Y; Michon B; Schorin MA; Cohen HJ; Neuberg DS; Orav EJ; Colan SD. "Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukemia: long-term follow-up of a prospective, randomized, multicentre trial." Lancet Oncol. 2010; 11: 950-61.

3/1/2008
Barry EV, Vrooman LM, Dahlberg SE, Neuberg DS, Asselin BL, Athale UH, Clavell LA, Larsen EC, Moghrabi A, Samson Y, Schorin MA, Cohen HJ, Lipshultz SE, Sallan SE, Silverman LB. "Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2008 Mar 1; 26(7):1106-11.

2008
Barry EV, Vrooman LM, Dahlberg SE, Neuberg DS, Asselin BL, Athale UH, Clavell LA, Larsen EC, Moghrabi A, Sanson Y, Schorin MA, Cohen HJ, Lipshultz SE, Sallan SE, and Silverman LB. "Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane." J Clin Oncol. 2008; 26(7): 1106-11.

9/1/2007
Winter SS, Jiang Z, Khawaja HM, Griffin T, Devidas M, Asselin BL, Larson RS, . "Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group." Blood.. 2007 Sep 1; 110(5):1429-38. Epub 2007 May 10.

6/2007
Salzer WL, Devidas M, Shuster JJ, Wang C, Chauvenet A, Asselin BL, Camitta BM, Kurtzberg J, . "Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group." Journal of pediatric hematology/oncology.. 2007 Jun 0; 29(6):369-75.

3/1/2007
Barry E, DeAngelo DJ, Neuberg D, Stevenson K, Loh ML, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Cohen HJ, Sallan SE, Silverman LB. "Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2007 Mar 1; 25(7):813-9.

2/2007
Moghrabi A, Levy DE, Asselin BL, Barr R, Clavell L, Hurwitz C, Samson Y, Schorin M, Dalton VK, Lipshultz SE, Neuberg DS, Gelberg RD, Cohen HJ. "Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia." Blood First Editioin Paper, prepublished online Sept 26, 2006. DOI 10.1182/blood-206-06-027714. 2007; 109(3): 896-904.

2007
Salzer WL, Devias M, Shuster JJ, Wang C, Chauvenet A, Asselin BL, Camitta BM and Kurtzberg J. "Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group." J Pediatr Hematol/Oncol. 2007; 29(6): 369-375.

2007
Avramis VI, Martin-Aragon S, Avramis EV, Asselin BL. "Pharmacoanalytical assays of Erwinia asparaginase (erwinase) and pharmacokinetic results in high-risk acute lymphoblastic leukemia (HR ALL) patients: simulations of erwinase population PK-PD models." Anticancer Res. 2007; 27(4C): 2561-72.

2007
Barry EV, Deangelo DJ, Neuberg DS, Loh MS, Asselin BL, Barr R, Clavell L, Hurwitz C, Moghrabi A, Samson Y, Schorin M, Cohen HJ, Sallan SE and Silverman LB. "Favorable Outcome for Adolescents with Acute Lymphoblastic Leukemia (ALL) Treated on Dana-Farber Cancer Institute (DFCI; Boston, MA) ALL Consortium Protocols." Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2007; 25(7): 813-9.

2007
Winter SS, Jiang Z, Khawaja H, Griffin T, Devidas M, Asselin BL, and Larsen RS. "Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group." Blood. 2007; 110(5): 1429-38.

2007
Avramis VI, Martin-Aragon S, Avramis EV, Asselin BL. "Pharmacoanalytical assays of Erwinia asparaginase (erwinase) and pharmacokinetic results in high-risk acute lymphoblastic leukemia (HR ALL) patients: simulations of erwinase population PK-PD models." Anticancer research.. 2007 27(4C):2561-72.

11/1/2005
Basu SK, Fernandez ID, Fisher SG, Asselin BL, Lyman GH. "Length of stay and mortality associated with febrile neutropenia among children with cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2005 Nov 1; 23(31):7958-66.

2005
Basu SK, Fernandez ID, Fisher SG, Asselin BL, and Lyman GH. "Length of stay and morbidity associated with febrile neutropenia among children with cancer." J Clin Oncol. 2005; 23(31): 7958-66.

7/8/2004
Lipshultz SE, Rifai N, Dalton VM, Levy DE, Silverman LB, Lipsitz SR, Colan SD, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Gelber RD, Sallan SE. "The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia." The New England journal of medicine.. 2004 Jul 8; 351(2):145-53.

2004
Lipshultz SE, Nader R, Dalton VM, Levy DE, Silverman LB, Lipsitz SR, Colan SD, Asselin BL, Barr, RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Gelber RD and Sallan SE. "The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia." N Engl J Med. 2004; 351(2): 145-53.

10/1/2003
Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE, Asselin BL. "Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2003 Oct 1; 21(19):3616-22.

8/1/2003
Dalton VK, Rue M, Silverman LB, Gelber RD, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Tarbell NJ, Sallan SE, Cohen LE. "Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2003 Aug 1; 21(15):2953-60.

2003
Dalton VK, Rue M, Silverman LB, Gelber RD, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samaon Y, Schorin M, Tarbell NJ, Sallan SE, and Cohen LE. "Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment." J Clin Oncol. 2003; 21(15): 2953-60.

2003
Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE and Asselin BL. "Childhood T-Cell Acute Lymphoblastic Leukemia (ALL): the Dana-Farber Cancer Institute ALL Consortium experience." J Clin Oncol. 2003; 21(19): 3616-22.

3/15/2002
Lipshultz SE, Giantris AL, Lipsitz SR, Kimball Dalton V, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Gelber RD, Sallan SE, Colan SD. "Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2002 Mar 15; 20(6):1677-82.

1/1/2002
LeClerc JM, Billett AL, Gelber RD, Dalton V, Tarbell N, Lipton JM, Barr R, Clavell LA, Asselin B, Hurwitz C, Schorin M, Lipshultz SE, Declerck L, Silverman LB, Cohen HJ, Sallan SE. "Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2002 Jan 1; 20(1):237-46.

2002
LeClerc JM, Billett AL, Gelber RD, Tarbell NJ, Lipton JM, Barr RD, Clavell LA, Asselin BL, Hurwitz CA, Schorin MA, Dalton VK, Declerck L, Cohen HJ and Sallan SE. "Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber ALL Consortium Protocol 87-01". J Clin Oncol. 2002; 20(1): 237-46.

2002
Lipshultz SE, Giantris AL, Lipsitz SR, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Gelber RD, Sallan SE, and Colan SD. "Doxorubicin administration by continuous infusion is not cardioprotective: The Dana-Farber 91-01 Acute Lymphoblastic Leukemia Protocol". J Clin Oncol. 2002; 20(6): 1677-82.

3/1/2001
Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Arkin S, Declerck L, Cohen HJ, Sallan SE. "Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01." Blood.. 2001 Mar 1; 97(5):1211-8.

2001
Silverman LB, Gelber RD, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Arkin S, Dalton VK, Zou G, Cohen HJ and Sallan SE. "Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-01." Blood. 2001; 97(5): 1211-8.

12/2000
Silverman LB, Declerck L, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Lipton JM, Cohen HJ, Sallan SE. "Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)." Leukemia.. 2000 Dec 0; 14(12):2247-56.

1999
Asselin BL, Kreissman S, Coppola DJ, Bernal SD, Leavitt PR, Gelber RD, Sallan SE, Cohen HJ. "Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia." Journal of pediatric hematology/oncology.. 1999 21(1):6-12.

1999
Asselin BL. "The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia." Advances in experimental medicine and biology.. 1999 457:621-9.

5/1998
Graham ML, Asselin BL, Herndon JE, Casey JR, Chaffee S, Ciocci GH, Daeschner CW, Davis AR, Gold S, Halperin EC, Laughlin MJ, Martin PL, Olson JF, Kurtzberg J. "Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia." Bone marrow transplantation.. 1998 May 0; 21(9):879-85.

1/1998
Giantris A, Abdurrahman L, Hinkle A, Asselin BL, Lipshultz S. "Anthracycline Induced Cardiotoxicity". Critical Reviews in Oncology-Hematology. 1998; 27: 53-68.

1998
Graham ML, Asselin, BL, Herndon JE, III, Casey JR, Chaffee S. Ciocci GH, Daeschner CW, Davis AR, Gold S, Halperin EC, Laughlin MJ, Martin PL, Olson JF, and Kurtzberg J. "Toxicity, pharmacology and feasibility of administration of PEG-L-Asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia." Bone Marrow Transplantation. 1998; 21(9): 879-85.

1997
Snitzer EL, Fultz PJ, Asselin B. "Magnetic resonance imaging appearance of fibromatosis colli." Magnetic resonance imaging.. 1997 15(7):869-71.

6/1996
Asselin BL. "Pegaspargase: A viewpoint". Clin Therapeutics. 1996; 5: 497-498.

6/1996
Korones DN, Buzzard CJ, Asselin BL, Harris JP. "Right atrial thrombi in children with cancer and indwelling catheters." The Journal of pediatrics.. 1996 Jun 0; 128(6):841-6.

1996
Korones DN, Buzzard CJ, Asselin BL and Harris JP. "Right atrial thrombi in children with cancer and indwelling catheters." Journal of Pediatrics. 1996; 128(6): 841-6.

9/1993
Asselin BL, Whitin JC, Coppola DJ, Rupp IP, Sallan SE, Cohen HJ. "Comparative pharmacokinetic studies of three asparaginase preparations." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1993 Sep 0; 11(9):1780-6.

3/13/1992
Asselin BL. "Evaluation of tumor cell heterogeneity based on response to chemotherapy." Clinica chimica acta; international journal of clinical chemistry.. 1992 Mar 13; 206(1-2):33-44.

1992
Stephens R, Asselin BL. "Application of the MTT assay to chemosensitivity testing using human leukemic cell lines". Journal Univ Rochester Medical Center. 1992; 3(2).

12/15/1991
Asselin BL, Lorenson MY, Whitin JC, Coppola DJ, Kende AS, Blakley RL, Cohen HJ. "Measurement of serum L-asparagine in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitor." Cancer research.. 1991 Dec 15; 51(24):6568-73.

4/1990
Asselin BL. "Clinical use of intravenous immunoglobulin". Hospital Therapy. 1990; 15(4): 479-439.

1990
Rupp IP*, Asselin BL, Whitin JC, Cohen HJ. "Clearance of L-asparaginase enzyme activity and protein". Journal Univ Rochester Medical Center. 1990; 2(2): 2-5.

8/1/1989
Asselin BL, Ryan D, Frantz CN, Bernal SD, Leavitt P, Sallan SE, Cohen HJ. "In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase." Cancer research.. 1989 Aug 1; 49(15):4363-8.

3/1987
Asselin BL, Lawrence RA. "Maternal disease as a consideration in lactation management." Clinics in perinatology.. 1987 Mar 0; 14(1):71-87.

Books & Chapters

2011
Chapter Title: "Epidemiology of Childhood and Adolescent Cancer" in Nelson Textbook of Pediatrics".
Book Title: Nelson Textbook of Pediatrics
Author List: BL Asselin
Edited By: ed. Kliegman RM, Behrman RE, Stanton BF, Schor N, and St.Geme J.
Published By: WB Saunders2011 in Philadelphia

2010
Chapter Title: Pediatric Leukemias and Lymphomas
Book Title: Textbook of Radiation Oncology
Author List: Asselin, BL; Hudson, M; Constine, LS
Edited By: Leibel S. Phillips
Published By: WB Saunders2010 in Philadelphia

2010
Chapter Title: Epidemiology of Childhood and Adolescent Cancer
Book Title: Nelson Textbook of Pediatrics, 19th ed.
Author List: Kliegman RM, Behrman RE, Stanton BF, Schor N, and St. Geme J
Published By: WB Saunders2010 in Philadelphia

2007
Chapter Title: Histiocytosis Syndromes
Book Title: Pediatric Clinical Advisor
Author List: Asselin BL.
Edited By: Garfunkel LC, Christy C, Kaczorowski J
Published By: CV. Mosby, Inc2007 in St. Louis, MO

2007
Chapter Title: Non-Hodgkin's Lymphoma
Book Title: Pediatric Clinical Advisor
Author List: Asselin BL
Edited By: Garfunkel LC, Christy C, Kaczorowski J
Published By: CV Mosby Inc.2007 in St. Louis, MO

2007
Chapter Title: Lymphomas in Children
Book Title: Principles and Practice of Radiation Oncology
Author List: Hudson M, Asselin BL, Constine LS
Edited By: Perez, Brady, Halperin
Published By: Lippincott, Williams and Wilkins, Inc.2007 in Philadelphia

2004
Chapter Title: "Lymphomas in Children"
Book Title: Principles and Practice of Radiation Oncology
Author List: Hudson M, Asselin BL, Mandell LR, Constine LS
Edited By: Perez, Brady, Halperin
Published By: Lippincott Williams & Wilkins2004 in Philadelphia, PA

2004
Chapter Title: "Pediatric Leukemias and Lymphomas"
Book Title: Textbook of Radiation Oncology
Author List: Asselin BL, Hudson M, Mandell L, Constine LS
Edited By: Leibel S, Phillips T
Published By: WB Saunders2004 in Philadelphia, PA

2003
Chapter Title: "Asparaginase"
Book Title: Treatment of Acute Leukemias: New Directions for Clinical Research
Author List: Asselin BL, Kurtzberg J
Edited By: Pui C-H
Published By: The Humana Press, Inc.2003

2001
Chapter Title: "Non-Hodgkin's Lymphoma"
Book Title: Pediatric Clinical Advisor
Author List: Asselin BL
Edited By: Garfunkel LC, Christy C, Kaczorowski J
Published By: C.V. Mosby, Inc.2001 in St. Louis, MO

2001
Chapter Title: "The Leukemias of Childhood"
Book Title: Primary Pediatric Care
Author List: Asselin BL
Edited By: R. Hoekelman, et al
Published By: C.V. Mosby Co.2001 in St. Louis, MO

2000
Book Title: Leukemia: Perspectives on disease and illness
Author List: Peacock J; Asselin BL (medical consultant)
Published By: Capstone Press2000 in Mankato, MN

1998
Chapter Title: "Hemolytic Anemia in Children"
Book Title: Current Pediatric Therapy
Author List: Asselin BL
Edited By: Burg FD, Ingelfinger JR, Polin RA, Wald ER
Published By: W.B. Saunders Co.1998

1997
Chapter Title: "The Leukemias of Childhood"
Book Title: Primary Pediatric Care
Author List: Asselin BL
Edited By: R. Hoekelman, et al
Published By: C.V. Mosby Co.1997 in St. Louis, MO

1997
Chapter Title: "Laboratory Monitoring of Asparaginase Therapy"
Book Title: Acute Lymphoblastic Leukemia- The Cutting Edge
Author List: Asselin BL
Edited By: Poplack D
Published By: Baylor-Sammons Cancer Center1997 in Dallas, TX

1997
Chapter Title: "Treatment for Childhood Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Consortium Experience"
Book Title: Acute Lymphoblastic Leukemia -The Cutting Edge
Author List: Silverman LB, Asselin BL, Sallan SE
Edited By: Poplack D
Published By: Baylor-Sammons Cancer Center1997 in Dallas, TX

1994
Chapter Title: "Nonimmune Hemolytic Anemia"
Book Title: Conn's Current Therapy
Author List: Asselin BL, Segel GB.
Edited By: R. Rakel
Published By: W.B. Saunders Co.1994

1992
Chapter Title: "The Leukemias of Childhood"
Book Title: Primary Pediatric Care
Author List: Asselin BL
Edited By: R. Hoekelman, et al
Published By: C.V. Mosby Co.1992 in St. Louis, MO